Kato Hitoshi, Nomura Kyoko, Osabe Dai, Shinohara Shuichi, Mizumori Osamu, Katashima Rumi, Iwasaki Shoji, Nishimura Koichi, Yoshino Masayasu, Kobori Masato, Ichiishi Eiichiro, Nakamura Naoto, Yoshikawa Toshikazu, Tanahashi Toshihito, Keshavarz Parvaneh, Kunika Kiyoshi, Moritani Maki, Kudo Eiji, Tsugawa Kazue, Takata Yoichiro, Hamada Daisuke, Yasui Natsuo, Miyamoto Tatsuro, Shiota Hiroshi, Inoue Hiroshi, Itakura Mitsuo
Molecular Medicine Research Laboratories, Drug Discovery Research, Astellas Pharma, Inc., Tokyo, Japan.
Genomics. 2006 Apr;87(4):446-58. doi: 10.1016/j.ygeno.2005.11.009. Epub 2006 Jan 10.
Several previous linkage scans in type 2 diabetes (T2D) families indicated a putative susceptibility locus on chromosome 12q15-q22, while the underlying gene for T2D has not yet been identified. We performed a region-wide association analysis on 12q15-q22, using a dense set of >500 single-nucleotide polymorphisms (SNPs), in 1492 unrelated Japanese individuals enrolled in this study. We identified an association between T2D and a haplotype block spanning 13.6 kb of genomic DNA that includes the entire SOCS2 gene. Evolutionary-based haplotype analysis of haplotype-tagging SNPs followed by a "sliding window" haplotypic analysis indicated SNPs that mapped to the 5' region of the SOCS2gene to be associated with T2D with high statistical significance. The SOCS2 gene was expressed ubiquitously in human and murine tissues, including pancreatic beta-cell lines. Adenovirus-mediated expression of the SOCS2 gene in MIN6 cells or isolated rat islets significantly suppressed glucose-stimulated insulin secretion. Our data indicate that SOCS2 may play a role in susceptibility to T2D in the Japanese.